glutamate system
Showing 1 - 25 of >10,000
Development ofNovel Glutamate Receptor Ligand for PET Scans in
Active, not recruiting
- Systemic Lupus Erythematosus
-
Manhasset, New YorkThe Feinstein Institute for Medical Research
Oct 11, 2021
Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)
Completed
- Lung Carcinoma
- +2 more
- Computed Tomography
- +5 more
-
Nashville, Tennessee
- +1 more
Oct 17, 2022
Cannabis Use Disorder Trial in New Haven ([18F]FPEB with PET, Cannabis abstinence)
Not yet recruiting
- Cannabis Use Disorder
- [18F]FPEB with PET
- Cannabis abstinence
-
New Haven, ConnecticutThe Anlyan Center
Dec 22, 2022
Bipolar Disorder Type II, Mood Depressive Disorder Trial in Clermont-Ferrand (NMR spectrometry)
Recruiting
- Bipolar Disorder Type II
- Mood Depressive Disorder
- NMR spectrometry
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Dec 6, 2022
Cocaine Use Disorder, Cocaine Dependence Trial in Zürich (Ketamine, Placebo, real-time fMRI neurofeedback training)
Not yet recruiting
- Cocaine Use Disorder
- Cocaine Dependence
- Ketamine
- +3 more
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich, University of Zurich
Nov 6, 2023
Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())
Recruiting
- Treatment Resistant Depression
- +2 more
- Ketamine Hydrochloride
- No intervention (placebo)
-
Oxford, United KingdomDepartment of Psychiatry, University of Oxford
Mar 28, 2023
Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion
Completed
- Coronary Artery Bypass
- +3 more
- Intravenous infusion of saline
- Intravenous glutamate infusion
-
Karlskrona, Sweden
- +2 more
May 21, 2022
Migraine Disorders, Migraine Without Aura, Headache Disorders, Primary Trial (Glyceryl trinitrate (I.V. infusion 0.5 µg/kg/min
Completed
- Migraine Disorders
- +6 more
- Glyceryl trinitrate (I.V. infusion 0.5 µg/kg/min over 20 min)
- (no location specified)
Jan 5, 2020
7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of
Not yet recruiting
- Rheumatoid Arthritis
- +4 more
- (no location specified)
Jan 16, 2023
Resistant Schizophrenia: A Longitudinal Magnetic Resonance
Active, not recruiting
- Schizophrenia
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 2, 2022
Parkinson's Disease Trial in Clermont-Ferrand, Poitiers (specific MRI Acquisition (NMR spectroscopy) at 7T)
Recruiting
- Parkinson's Disease
- specific MRI Acquisition (NMR spectroscopy) at 7T
-
Clermont-Ferrand, France
- +1 more
Apr 8, 2022
Probing Rheumatoid Arthritis Brain to Elucidate Central Pain
Recruiting
- Rheumatoid Arthritis
-
Glasgow, Scotland, United KingdomQueen Elizabeth University Hospital
Jan 11, 2023
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Psychosis, Negative Symptoms With Primary Psychotic Disorder Trial in Glostrup (Memantine, Placebo)
Recruiting
- Psychosis
- Negative Symptoms With Primary Psychotic Disorder
- Memantine
- Placebo
-
Glostrup, Capitol Region, DenmarkCentre for Neuropsychiatric Schizophrenia Research, CNSR & Centr
Aug 23, 2021
Alcohol Use Disorder, Depressive Disorder, Cigarette Smoking Trial in Palo Alto, Stanford (Intermittent theta burst transcranial
Completed
- Alcohol Use Disorder
- +2 more
- Intermittent theta burst transcranial magnetic stimulation
-
Palo Alto, California
- +1 more
Aug 17, 2022
Schizophrenia, Cognitive Deficits, Schizophrenia; Negative Type Trial in Los Angeles (N-acetylcysteine, Treatment as Usual)
Unknown status
- Schizophrenia
- +2 more
- N-acetylcysteine
- Treatment as Usual
-
Los Angeles, CaliforniaUCLA Semel Institute for Neuroscience and Human Behavior
Feb 18, 2021
Inflammation, Fatigue Trial in Atlanta (Riluzole, Placebo)
Completed
- Inflammation
- Fatigue
- Riluzole
- Placebo
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Mar 24, 2021
Clinical High Risk for Psychosis Trial in New York (Pomaglumetad methionil)
Completed
- Clinical High Risk for Psychosis
- Pomaglumetad methionil
-
New York, New YorkNew York State Psychiatric Institute
Nov 5, 2021
Cerebrovascular Stroke Trial in Madrid (Hemodialysis)
Recruiting
- Cerebrovascular Stroke
- Hemodialysis
-
Madrid, SpainJosé Vivancos Mora, MD., PhD
Dec 30, 2021
A Study of Metabolic Agents Following Brain Radiation
Enrolling by invitation
- CNS Malignancy
- F-DOPA Positron Emission Tomography
- Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
-
Rochester, MinnesotaMayo Clinic
Nov 21, 2023